EUVIMEDEUVIMED entdecken
Open Access

Prognostic Factors and Optimal Empiric Therapy for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales Bacteremia

Tadashi Maeda, Sohei Harada, Dai Nakase, Yusuke Nakamura, Takeo Mori, Katsuhito Kashiwagi, Takahiro Sato, Taito Miyazaki, Yosuke Sasaki

Cureus · 27.11.2025

DOI: 10.7759/cureus.97980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 27.11.2025. Verfasst von Tadashi Maeda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine and Emergency Care, Toho University School of Medicine, Tokyo, JPN. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

bacteremiaempiric antimicrobial therapyesbl-producing enterobacteralesprognostic factorsqsofa score

Autor:innen und Institutionen

  • Department of General Medicine and Emergency Care, Toho University School of Medicine, Tokyo, JPN.
  • Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, JPN.

Zitieren

APA

Maeda, T., Harada, S., Nakase, D., Nakamura, Y., Mori, T., Kashiwagi, K., Sato, T., Miyazaki, T., & Sasaki, Y. (2025). Prognostic Factors and Optimal Empiric Therapy for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales Bacteremia. Cureus. https://doi.org/10.7759/cureus.97980

Vancouver

Maeda T, Harada S, Nakase D, Nakamura Y, Mori T, Kashiwagi K, et al. Prognostic Factors and Optimal Empiric Therapy for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales Bacteremia. Cureus. 2025. doi:10.7759/cureus.97980

BibTeX
@article{Maeda2025,
  author = {Maeda, Tadashi and Harada, Sohei and Nakase, Dai and Nakamura, Yusuke and Mori, Takeo and Kashiwagi, Katsuhito and Sato, Takahiro and Miyazaki, Taito and Sasaki, Yosuke},
  title = {Prognostic Factors and Optimal Empiric Therapy for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales Bacteremia},
  journal = {Cureus},
  year = {2025},
  doi = {10.7759/cureus.97980}
}
Kostenlos starten →